Bioventus Inc. (BVS) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Bioventus Inc. (BVS:NASDAQ), powered by AI.

Current Price
$8.51
Sector
Healthcare
What is the Bioventus Inc. stock price forecast?

Bioventus Inc. is currently trading at $8.51. View real-time AI analysis on Alpha Lenz.

What is Bioventus Inc. insider trading activity?

View the latest insider trading data for Bioventus Inc. on Alpha Lenz.

What is Bioventus Inc.'s P/E ratio?

View Bioventus Inc.'s valuation metrics on Alpha Lenz.

Bioventus Inc.

NASDAQ · BVS
$8.51-0.17(-1.96%)Pre-marketNASDAQ regular session 09:30–16:00 ET
Ask about Bioventus Inc.'s future dividend policy...
Alpha Chat Insight

Bioventus Inc.'s ROE is 13.7%. Explore profitability and growth together.

Ask for details

Company Overview

Bioventus Inc. operates as a medical device company focused on developing innovative medical solutions for musculoskeletal healing. Primarily, it seeks to enhance patients' quality of life through its products that aid in bone healing, pain management, and osteoarthritis care. The company's notable product categories include bone health products, joint pain products, and surgical solutions, which serve a critical role in orthopedics and sports medicine. Headquartered in Durham, North Carolina, Bioventus leverages advanced biological technologies to drive advancements in healthcare. By providing both surgical and non-surgical therapies, it plays a pivotal role in the market for enhancing patient recovery and addressing orthopedic ailments. Bioventus’ contributions are significant in clinical settings and for patients seeking less invasive alternatives to traditional treatments, marking it as a key player in the intersection of medical technology and patient care.

CEOMr. Robert E. Claypoole
SectorHealthcare
IndustryMedical Devices
Employees950

Company Statistics

FY 2025

Profile

N/AMarket Cap
$568.09MRevenue
0.00Shares Out
950Employees

Margins

68.33%Gross
17.93%EBITDA
9.91%Operating
4.53%Pre-Tax
4.80%Net

Valuation

N/AP/E
N/AP/B
N/AEV/Sales
N/AEV/EBITDA
N/AP/FCF

Growth (CAGR)

3.52%Rev 3Yr
12.08%Rev 5Yr
N/AOp Inc 3Yr
20.89%Op Inc 5Yr
N/ANet Inc 3Yr
13.12%Net Inc 5Yr

Returns

3.86%ROA
13.69%ROE
7.40%ROIC

Financial Health

$51.24MCash & Cash Equivalents
$403.87MNet Debt
199.22%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Bioventus Inc. (ticker: BVS) is a company listed on NASDAQ in the Healthcare sector (Medical Devices). It has approximately 950 employees.

The current price is $8.51 with a P/E ratio of -x and P/B of -x.

ROE is 13.69% and operating margin is 9.91%. Annual revenue is $568M.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Bioventus Inc. (BVS) Stock Forecast 2026 $8.51 — Price, Financials & Analyst Targets | Alpha Lenz